KPWS
CBAY

Kestra Private Wealth Services’s Cymabay Therapeutics CBAY Stock Holding History

Kestra Private Wealth Services’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-501,000
Closed -$1.83M – 1035
2021
Q3 		$1.83M Hold
501,000
– – 0.1% 220
2021
Q2 		$2.18M Buy
+501,000
New +$2.22M 0.13% 170
2021
Q1 		– Sell
-401,000
Closed -$2.36M – 855
2020
Q4 		$2.36M Buy
401,000
+101,000
+34% +$765K 0.17% 140
2020
Q3 		$2.5M Buy
+300,000
New +$1.6M 0.22% 108

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Kestra Private Wealth Services's CBAY Position: Q4 2021 in Review

Kestra Private Wealth Services sold out of Cymabay Therapeutics (CBAY) in Q4 2021, closing a stake of 501,000 shares — an estimated $1.83M sold.

Kestra Private Wealth Services first reported a position in CBAY in Q3 2020 and held it in 4 quarters. The position peaked at $2.5M in Q3 2020. 113 funds tracked by Wall St. Rank hold CBAY as of Q4 2021.

  • Kestra Private Wealth Services reported no remaining Cymabay Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Kestra Private Wealth Services sold 501,000 Cymabay Therapeutics shares in Q4 2021, an estimated $1.83M.
  • Kestra Private Wealth Services first reported a position in Cymabay Therapeutics in Q3 2020 and held it in 4 quarters.
  • Kestra Private Wealth Services's Cymabay Therapeutics position peaked at $2.5M in Q3 2020.
  • 113 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2021.

Based on Kestra Private Wealth Services's 13F filing for Q4 2021, filed 21 Jan 2022.